2023

1. Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: Results from a 52-Week Open-Label Phase IV Clinical Trial (DIMESKIN 1)

   Dermatology and Therapy, Vol. 13, Núm. 1, pp. 329-345